<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DEF5B792-E941-4197-8F2B-A74193BA0CC4"><gtr:id>DEF5B792-E941-4197-8F2B-A74193BA0CC4</gtr:id><gtr:name>Amsterdam Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/395F850A-031E-45AD-817A-4C46D042B92C"><gtr:id>395F850A-031E-45AD-817A-4C46D042B92C</gtr:id><gtr:name>University of Cincinnati</gtr:name><gtr:address><gtr:line1>University of Cincinnati</gtr:line1><gtr:line2>2624 Clifton Avenue</gtr:line2><gtr:postCode>OH 45221-0</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DEF5B792-E941-4197-8F2B-A74193BA0CC4"><gtr:id>DEF5B792-E941-4197-8F2B-A74193BA0CC4</gtr:id><gtr:name>Amsterdam Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/395F850A-031E-45AD-817A-4C46D042B92C"><gtr:id>395F850A-031E-45AD-817A-4C46D042B92C</gtr:id><gtr:name>University of Cincinnati</gtr:name><gtr:address><gtr:line1>University of Cincinnati</gtr:line1><gtr:line2>2624 Clifton Avenue</gtr:line2><gtr:postCode>OH 45221-0</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2F80D731-26B2-413F-9B96-F9E5115AEADF"><gtr:id>2F80D731-26B2-413F-9B96-F9E5115AEADF</gtr:id><gtr:firstName>Aubrey</gtr:firstName><gtr:surname>Cunnington</gtr:surname><gtr:orcidId>0000-0002-1305-3529</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL006529%2F1"><gtr:id>F7F5EC9F-C417-4AD8-B48F-273810081051</gtr:id><gtr:title>IDENTIFYING HOST-PATHOGEN INTERACTIONS WHICH CAUSE SEVERE MALARIA</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/L006529/1</gtr:grantReference><gtr:abstractText>Infectious diseases continuously challenge the body's defenses. Perhaps surprisingly, we know rather little about how many infections actually cause serious illness. Often we can't explain why the same infection causes mild illness in one person but kills another. Finding out why this happens is key to finding better treatments.

Malaria is one infection we need to understand better. It is a disease caused by tiny parasites within red blood cells which are spread from person to person by the bite of mosquitoes. Malaria infects more than 200 million people every year around the world and kills almost 1 million of them. Some features linked to severe infections have been identified, but we don't really know how these lead to severe illness and death.

This research aims to explain how interactions between the body's defenses and the malaria parasite result in differences in the severity of illness. We aim to use a new technique to do this. We will look at all the genes that are simultaneously active in the malaria parasite and the human cells in the blood, to find patterns associated with severe illness. Malaria is an ideal disease to assess with our new technique because all of the parasites live in the blood. This research will help to identify new approaches to the treatment of severe malaria. This could save many lives in the future. If we are successful, we think the approach could also be applied to many other infectious diseases. 

This research will be carried out by collaborating scientists at Imperial College London, The London School of Hygiene and Tropical Medicine, University of Queensland (Australia), National Institutes of Health (USA) and MRC Laboratories, The Gambia. It draws together world leaders in malaria research, genetics, computing methods and statistics. The research will use stored samples collected from Gambian children with malaria. Some of these children had a mild illness, and some had life-threatening complications. The activity of all the human and parasite genes will be measured with a technique called &amp;quot;RNA Sequencing&amp;quot;. A series of advanced computer techniques will be used to find the patterns of gene activity associated with severity of malaria. Once we have identified the patterns associated with severe malaria we will test them in the laboratory to see if we can target them to prevent severe malaria. We do this by deliberately altering genes, or by adding or blocking molecules that are important in generating the patterns we identify. This allows us to be sure our findings are causal, rather than just chance associations. The raw data and all our findings will be made publically available, so that other scientists can use the data to answer other important questions about malaria.</gtr:abstractText><gtr:technicalSummary>Aim: To explain how host and pathogen interact to cause different severe malaria syndromes. 

Objectives:
1. a) To use RNA sequencing to identify differences in human and parasite gene expression which characterize cerebral malaria and hyperlactataemia. 
b) To identify key host and parasite pathways in cerebral malaria and hyperlactataemia.
c) To determine interactions between host and parasite gene expression and features of severe malaria. 
2. To assess how well experimental malaria infections in mice represent severe malaria in humans by comparative gene expression analysis.
3. To test the relevance of novel candidate pathways and host-pathogen interactions by manipulation in vitro and in vivo. 

Methodology: Dual RNA-Sequencing will be performed on archived whole blood RNA from Gambian children with different malaria syndromes. Differential expression of genes, pathway analysis and interaction analysis will be performed to identify mechanisms associated with severe malaria. Based on existing literature, and selective experiments, we will assess to what extent different combinations of mouse and Plasmodium species exhibit similar profiles of gene and pathway activity to human severe malaria. To validate the findings from the global gene expression analysis we will test selected pathways in culture systems involving parasites, endothelial cells and leukocytes, and in vivo where homologous pathways exist.

Scientific Opportunities: This project should identify novel pathways which determine the phenotype of severe malaria, has the possibility to identify the importance of reciprocal interactions between host and pathogen in causing disease, and will generate a useful, publicly available, dataset of global host and parasite gene expression.

Medical Opportunities: The identification of novel mechanisms involved in different severe malaria syndromes may allow tailored treatment of each syndrome, and development of much needed adjunctive therapies.</gtr:technicalSummary><gtr:potentialImpactText>ACADEMIC IMPACTS

Enhancing Knowledge: The most direct impact will be expansion of knowledge about malaria. This knowledge will have immediate applicability to guide other research on basic and clinical aspects of malaria, by academics and the pharmaceutical industry. Within 5-10 years, it may also change the direction of infectious disease research to explore what host factors alter pathogen behavior, and may be applied to other situations where virulence traits appear to be selected and persist. The knowledge and conceptual impacts will be delivered by peer reviewed publication, presentation of the research outputs at National and International conferences, and through press releases. 

New Methodologies: Pioneering the &amp;quot;dual RNA sequencing&amp;quot; technique will demonstrate its usefulness to other researchers. The methods will be disseminated promptly and communicated in a similar way to the knowledge impact, becoming available from the second or third year of the project. Participation in on-line forums and technology congresses for discussion of methodology, and presentation on our group website, will ensure that these techniques are disseminated to the research and industrial communities. 

Creation of Resources: All the sequencing data and accompanying data will be uploaded to a public repository, and any novel analysis software will be made publically available. This will allow free secondary analysis of our data. Access to these resources will be highlighted in publications, presentations, and from our website, and made available simultaneously with any publications, between 2-5 years from the start of the project.

Individuals and skills. The experience and specific training during the five year period, will increase academic competitiveness for myself and collaborating researchers, particularly for the use of high throughput sequencing technologies integrated into future research plans. 
 

ECONOMIC AND SOCIETAL IMPACTS

Changing policy: If this research demonstrates differences in the pathogenesis of severe malaria syndromes, this could seed wide reaching consequences for policy on treatment, drug trials and vaccine evaluation. These implications will be discussed when we present our data throughout the fellowship, and disseminated through email discussion forums like CHILD2015, and by direct communication with Global organizations like WHO. Health Services in malaria endemic countries, Pharmaceutical Companies and their Regulators may all be affected, with global economic impacts over 10-15 years. 

Health and wellbeing: We hope this research will identify new strategies to treat severe malaria. Translational research could be undertaken by our own research group and collaborators, or others based on our published findings. It is likely to take at least 10 years for any new strategies to reach the clinic and improve the outcome of individuals with severe malaria in endemic countries.

Ethical society: We aim to constantly reduce, refine or replace the use of animals in our research because society expects animals to be used only when other methods are not possible. Part of this research aims to refine the use of mice to study severe malaria, and we anticipate that this will led to reductions in animal use. If successful, we will disseminate this approach through professional and public media, aiming to persuade others to consider its adoption over the next 4-10 years. 

Wealth creation: This research showcases the expertise of UK centres in apply cutting edge cross-disciplinary technology and techniques. It will highlight the academic prowess of the institutions, increasing investment from academic and commercial sector collaborators. The unique skills and opportunities will be highlighted on our group and institutional websites, and will be promoted by our institutions.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1233038</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Amsterdam Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Amsterdam Factor-H</gtr:description><gtr:id>788CBC48-109B-413D-92C9-4F07525CE592</gtr:id><gtr:impact>Results submit for conference abstract, manuscript in preparation. No publications yet</gtr:impact><gtr:outcomeId>58949e838753d2.18178001-1</gtr:outcomeId><gtr:partnerContribution>Developed in house ELISAs for factor-H and factor-H related proteins, performed ELISAs on my samples</gtr:partnerContribution><gtr:piContribution>We have provided samples from our malaria cohort for analysis of the association between factor H levels and severity</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Queensland</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Institute for Molecular Bioscience</gtr:department><gtr:description>Institute for Molecular Bioscience</gtr:description><gtr:id>F2F77F33-259E-4332-BB05-F00E27E2A8FE</gtr:id><gtr:impact>Early results submitted as conference abstract
Multidisciplinary- clinical / biology / bioinformatics</gtr:impact><gtr:outcomeId>56b8c5847ea720.28821760-1</gtr:outcomeId><gtr:partnerContribution>Bioinformatic analysis</gtr:partnerContribution><gtr:piContribution>Collaborative analysis on RNA-Seq data. We obtained the clinical specimens and performed the RNA-sequencing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cincinnati</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cincinnati</gtr:description><gtr:id>47104258-903A-4177-A5BF-95C38644356D</gtr:id><gtr:impact>No outcomes, initial experiments could not continue due to funding
Multi-disciplinary: immunology/clinical</gtr:impact><gtr:outcomeId>56b89452631801.94753237-1</gtr:outcomeId><gtr:partnerContribution>Conducted experiments to assess the effect of genetic deficiency of the target molecule in mice</gtr:partnerContribution><gtr:piContribution>We provided data to support a novel mechanism controlling parasite load in malaria in humans</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Population Health</gtr:department><gtr:description>Asymptomatic malaria transcriptome</gtr:description><gtr:id>79108958-DE27-4988-8FBD-999FC0455C33</gtr:id><gtr:impact>None yet, only just started</gtr:impact><gtr:outcomeId>5894a077e068d6.96204161-1</gtr:outcomeId><gtr:partnerContribution>Immunology and samples from age, sex and parasitemia matched children with asypmtomatic and uncomplicated malaria</gtr:partnerContribution><gtr:piContribution>RNA-sequencing analysis skills</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>LSHTM</gtr:description><gtr:id>F32C0F12-15F2-4383-A6FD-131EBD7129BF</gtr:id><gtr:impact>None, yet</gtr:impact><gtr:outcomeId>54481deadac984.85730868-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators will be helping to analyse and validate expression of Plasmodium falciparum genes and assess functional consequences in in vitro and in vivo models</gtr:partnerContribution><gtr:piContribution>In this collaborative project we are generating RNA sequencing data on human and Plasmodium falciparum RNA which we will analyse with our collaborators</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>MRC laboratories, The Gambia</gtr:description><gtr:id>A8464DDE-30BF-43E9-866B-5EEF8754FBD6</gtr:id><gtr:impact>None, yet</gtr:impact><gtr:outcomeId>54481eec672927.55544375-1</gtr:outcomeId><gtr:partnerContribution>Sharing of archived clinical samples, and collection of additional samples for RNA sequencing</gtr:partnerContribution><gtr:piContribution>Identification of stored samples with maximum potential for host-pathogen interaction research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Yale</gtr:description><gtr:id>4A2025D2-9BF2-498E-A2B1-B195667F598B</gtr:id><gtr:impact>None, yet</gtr:impact><gtr:outcomeId>54481fc32946b4.48720530-1</gtr:outcomeId><gtr:partnerContribution>Provided laboratory space, reagents, equipment and knockout mice to undertake a pilot experiment</gtr:partnerContribution><gtr:piContribution>Idenitified a novel target host gene that may control parasite replication in malaria</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Feedback visit Brikama and JFP</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B2575382-0E46-431E-907A-106737367DEB</gtr:id><gtr:impact>Community meetings at two health centres in the Gambia with local community leaders, healthcare staff, patient representatives and study teams, to feedback results from a large programme of research, share plans about future research using samples from this community, and to find out their views on future research priorities.

Local community leaders expressed a strong desire for ongoing work in their areas to improve treatment and prevention of malaria.</gtr:impact><gtr:outcomeId>5448d2fef167e5.56474871</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AHSC</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BD19602D-C3C5-4C8F-B186-2A0C84672AA8</gtr:id><gtr:impact>Showcased my research in the form of a giant jigsaw puzzle at the inauguration event for the Academic Health Sciences Centre

Raised the profile of the section of Paediatrics</gtr:impact><gtr:outcomeId>5448d50eaabf37.08432197</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting Nuffield Studentship</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BA94002E-5B32-4E20-A7FC-C981BF3669C3</gtr:id><gtr:impact>I hosted a 6th form student to undertake a small research project as part of a Nuffield Studentship</gtr:impact><gtr:outcomeId>5894a1fce6d339.77271029</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sky News other media interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48B8AE13-CB6D-4E05-A229-84DABFD3C6B8</gtr:id><gtr:impact>I was interviewed on Sky News Sunrise programme about an editorial written in the BMJ warning about the possible risks of a new birth trend - vaginal seeding.
I also responded to a lot of other media queries about this!</gtr:impact><gtr:outcomeId>56cd84ea68aac1.82204184</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://news.sky.com/story/1647538/health-of-babies-at-risk-over-seeding</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>42360</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:fundingRef>A951</gtr:fundingRef><gtr:id>5A9F5D37-39AA-447C-B79A-4D3BB1FDC5CD</gtr:id><gtr:outcomeId>56b8c3df8040e7.92208969</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Yale Liver Centre Grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Yale University</gtr:fundingOrg><gtr:id>0220D9D4-D049-48DF-89A1-EC670C519DCB</gtr:id><gtr:outcomeId>56b8c42d8788d2.60394070</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>EU Horizon 2020</gtr:description><gtr:end>2021-02-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>31855D44-F039-457B-AB15-4F227510A030</gtr:id><gtr:outcomeId>58a21e26de4998.55154616</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Guidance on Vaginal Seeding</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AE1FEE26-5CD6-4CE9-99FE-6470D082366A</gtr:id><gtr:outcomeId>56cd85bcec37f2.84883960</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type><gtr:url>http://www.bmj.com/content/352/bmj.i227.full?ijkey=PzgS42uArAr4Web&amp;keytype=ref</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We have developed a computer model to relate real patient data from subjects with malaria to the dynamic pattern of change in pathogen load</gtr:description><gtr:id>0AF9E4A3-643E-4CFF-9B37-95518437113D</gtr:id><gtr:impact>We have a manuscript in preparation - we believe this will stimulate a paradigm shift in the way people interpret host responses to infectious diseases</gtr:impact><gtr:outcomeId>5448d41fb941f2.78843104</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>TNF model</gtr:title><gtr:type>Computer model/algorithm</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed an approach to estimate parasite multiplication and killing rates in humans with malaria from measurements made at the single time point of clinical presentation. This allows us to model the preceding dynamics of infection in individual patients, and to identify host and parasite factors which control them.</gtr:description><gtr:id>49887C72-422F-43D8-9275-B64F25F2E26D</gtr:id><gtr:impact>We are currently combining the estimates made from this model with transcriptomic data to identify novel correlates of protection. We have not yet published this method</gtr:impact><gtr:outcomeId>56b8c73c366471.07434995</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Model of within-host dynamics of malaria in humans</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B0FB83DF-808A-4833-843F-956E2F6F578E</gtr:id><gtr:title>Infection-related hemolysis and susceptibility to Gram-negative bacterial co-infection.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8150e0392cb66679a00c3f2e6cbd0371"><gtr:id>8150e0392cb66679a00c3f2e6cbd0371</gtr:id><gtr:otherNames>Orf K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5675e8752eade</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>859AFCAD-2D62-4EBD-AB20-24F86FE217D9</gtr:id><gtr:title>The importance of pathogen load.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b74fb834b1126e5527514c363533f630"><gtr:id>b74fb834b1126e5527514c363533f630</gtr:id><gtr:otherNames>Cunnington AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5675de62f3e1b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D82464EC-C5FF-4BAE-A7A8-42624027A7F8</gtr:id><gtr:title>Invasive bacterial infections in Gambians with sickle cell anemia in an era of widespread pneumococcal and hemophilus influenzae type b vaccination.</gtr:title><gtr:parentPublicationTitle>Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c25acc36b00ae2009b567c71048591a"><gtr:id>2c25acc36b00ae2009b567c71048591a</gtr:id><gtr:otherNames>Soothill G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0025-7974</gtr:issn><gtr:outcomeId>588b5b5c8cca29.76874356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D84C11A1-DAD4-4FB9-8220-8321859E6895</gtr:id><gtr:title>Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050bffc65c8424ce1a92bf9d7d2e78d0"><gtr:id>050bffc65c8424ce1a92bf9d7d2e78d0</gtr:id><gtr:otherNames>Chertow JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56b892e1602c47.70746624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C17CB00-A66C-4C64-A4BB-1828EC4B73BB</gtr:id><gtr:title>Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6a1d50ea11f9d6a6fc49721bd0ab613"><gtr:id>c6a1d50ea11f9d6a6fc49721bd0ab613</gtr:id><gtr:otherNames>Evans C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>56b892e195ae64.90790957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>559F03D5-AA9A-4E6E-A06A-D29C97C4AFBD</gtr:id><gtr:title>&amp;quot;Vaginal seeding&amp;quot; of infants born by caesarean section.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b74fb834b1126e5527514c363533f630"><gtr:id>b74fb834b1126e5527514c363533f630</gtr:id><gtr:otherNames>Cunnington AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56cd831ae56729.52369143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05A20354-F8E7-41F6-881E-747E1CC3F5C5</gtr:id><gtr:title>Determinants of Carboxyhemoglobin Levels and Relationship with Sepsis in a Retrospective Cohort of Preterm Neonates.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/141575ad4d78bfb8cdc8a9d918b93dd6"><gtr:id>141575ad4d78bfb8cdc8a9d918b93dd6</gtr:id><gtr:otherNames>McArdle AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d3f191fa3c0.42763375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52AF811E-CC52-4A73-BC11-A0EFA6D28A37</gtr:id><gtr:title>The association between malaria and non-typhoid Salmonella bacteraemia in children in sub-Saharan Africa: a literature review.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8058b7c6c5abb64b256042cc8e56102"><gtr:id>b8058b7c6c5abb64b256042cc8e56102</gtr:id><gtr:otherNames>Takem EN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>54481be1027956.66923972</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L006529/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>